Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Director departure
Appointed director
Vanda Pharmaceuticals Inc. (VNDA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 SC 13G/A BlackRock Inc. reports a 11.8% stake in VANDA PHARMACEUTICALS INC
02/14/2023 SC 13G/A MACQUARIE GROUP LTD reports a 2.3% stake in Vanda Pharmaceuticals Inc.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 7% stake in Vanda Pharmaceuticals Inc.
02/07/2023 SC 13G/A STATE STREET CORP reports a 6.6% stake in AMENDED FILING VANDA PHARMACEUTICALS INC
02/14/2022 SC 13G/A ARMISTICE CAPITAL, LLC reports a 0% stake in Vanda Pharmaceuticals Inc.
02/14/2022 SC 13G/A Palo Alto Investors LP reports a 5.1% stake in Vanda Pharmaceuticals, Inc.
02/14/2022 SC 13G/A MACQUARIE GROUP LTD reports a 5.2% stake in Vanda Pharmaceuticals Inc.
02/11/2022 SC 13G/A STATE STREET CORP reports a 6% stake in AMENDED FILING VANDA PHARMACEUTICALS INC
02/11/2022 SC 13G/A RENAISSANCE TECHNOLOGIES LLC reports a 5.8% stake in VANDA PHARMACEUTICALS INC.
02/10/2022 SC 13G/A VANGUARD GROUP INC reports a 7% stake in Vanda Pharmaceuticals Inc.
01/27/2022 SC 13G/A BlackRock Inc. reports a 17.6% stake in VANDA PHARMACEUTICALS INC
01/26/2022 SC 13G/A BlackRock Inc. reports a 17.6% stake in VANDA PHARMACEUTICALS INC
02/16/2021 SC 13G/A ARMISTICE CAPITAL, LLC reports a 9.8% stake in Vanda Pharmaceuticals Inc.
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A MACQUARIE GROUP LTD reports a 5.8% stake in Vanda Pharmaceuticals Inc.
02/11/2021 SC 13G/A RENAISSANCE TECHNOLOGIES LLC reports a 7.3% stake in VANDA PHARMACEUTICALS INC.
02/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020 SC 13G/A Consonance Capital Management LP reports a 0% stake in VANDA PHARMACEUTICALS INC
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2020 SC 13G/A BlackRock Inc. reports a 17.6% stake in VANDA PHARMACEUTICALS INC
02/19/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2019 SC 13G/A VANGUARD GROUP INC reports a 7.9% stake in Vanda Pharmaceuticals Inc
01/31/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/10/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy